Edwards Lifesciences Corporation
MX ˙ BMV ˙ US28176E1082
SecurityMX:EW / Edwards Lifesciences Corporation
InstitutionSuvretta Capital Management, Llc
Latest Disclosed Ownership18,700 shares
Latest Disclosed Value $ 1,497,496
Suvretta Capital Management, Llc reports 68.47% increase in ownership of EW / Edwards Lifesciences Corporation

On May 15, 2026 - Suvretta Capital Management, Llc filed a 13F-HR form disclosing ownership of 18,700 shares of Edwards Lifesciences Corporation (MX:EW) valued at $1,497,496 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 11,100 shares of Edwards Lifesciences Corporation. This represents a change in shares of 68.47% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 18,700 7,600 68.47 1,497 58.25 0.0382
2026-02-17 2025-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 946 9.62 0.0194
2025-11-14 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 863 -0.58 0.0221
2025-08-14 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 868 7.96 0.0262
2025-05-15 2025-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 805 -2.07 0.0299
2025-02-14 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 822 12.16 0.0280
2024-11-14 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 732 -28.59 0.0234
2024-08-14 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 0 0.00 1,025 -3.30 0.0377
2024-05-15 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,100 11,100 1,061 0.0394
2023-11-14 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 0 -2,300 -100.00 0 -100.00
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,300 2,300 217 0.0116
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.